Overview of atopic dermatitis. C Avena-Woods The American journal of managed care 23 (8 Suppl), S115-S123, 2017 | 380 | 2017 |
Febuxostat (Uloric), A New Treatment Option for Gout C Avena-Woods, O Hilas Pharmacy and Therapeutics 35 (2), 82, 2010 | 24 | 2010 |
Potential Role of Mirtazapine in Underweight Older Adults O Hilas, C Avena-Woods The Consultant Pharmacist 29 (2), 124-130, 2014 | 19 | 2014 |
Exploring the community pharmacist’s knowledge of celiac disease C Avena-Woods, RA Mangione, WK Wu American Journal of Pharmaceutical Education 82 (2), 2018 | 11 | 2018 |
Antidepressant Use in Underweight Older Adults C Avena-Woods, O Hilas The Consultant Pharmacist 27 (12), 868-870, 2012 | 6 | 2012 |
Irritable Bowel Syndrome Treatment Options-This disorder is hard to diagnose and does not have an established cure. TJ Cannova, C Avena-Woods, TZ Jodlowski US Pharmacist 37 (12), 45, 2012 | 3* | 2012 |
Providing Immunizations in the Early Stages of the COVID-19 Pandemic; A Community Pharmacist and Student Pharmacist's View N Yioupis, S Villa, NJ Ryan-Bloom, C Avena-Woods Journal of Vincentian Social Action 6 (1), 9, 2022 | | 2022 |
Concerns Regarding Gluten Presence in Medicines Is Common Among Individuals with Celiac Disease, Dermatitis Herpetiformis, and Non-Celiac Gluten Sensitivity L Jay, HS Al-Lami, S Pal, DV Ajmera, C Avena-Woods, SW Zito, GG Sarris, ... Gastroenterology 152 (5), S484-S485, 2017 | | 2017 |
Smoking cessation and the pharmacist-patient relationship C Kim, J Shim, C Avena-Woods, BS Pharm Advanstar Communications Inc, 2014 | | 2014 |
Possession and management of medication lists among seniors residing in the community and the role of the pharmacist. C Avena-Woods, D Ezzo, A Cheng PHARMACOTHERAPY 33 (5), E66-E66, 2013 | | 2013 |
2 CE Credits Significant exposure to hazardous materials has been associated with an increased risk of developing pulmonary illnesses, especially asbestosis, lung cancer, and … C Avena-Woods, O Hilas US Pharmacist 35 (7), 54, 2010 | | 2010 |